4-Methylmorpholine → HCID 90039588, 화합물
반응식
[F:1][C:2]([F:17])([F:16])[CH:3]([C:5]1[CH2:6][C:7](F)([C:11]([F:14])([F:13])[F:12])[CH:8]=[CH:9][CH:10]=1)[NH2:4].[CH3:18][O:19][C:20]([C:22]1[CH:23]=[C:24]2[CH:31]=[C:30]([C:32](O)=[O:33])[NH:29][C:25]2=[N:26][C:27]=1[CH3:28])=[O:21].F[P-](F)(F)(F)(F)F.N1(OC(N(C)C)=[N+](C)C)C2C=CC=CC=2N=N1.CN1CCOCC1>CN(C)C=O.O>[CH3:28][C:27]1[N:26]=[C:25]2[NH:29][C:30]([C:32](=[O:33])[NH:4][CH:3]([C:5]3[CH:10]=[CH:9][CH:8]=[C:7]([C:11]([F:14])([F:13])[F:12])[CH:6]=3)[C:2]([F:17])([F:16])[F:1])=[CH:31][C:24]2=[CH:23][C:22]=1[C:20]([O:19][CH3:18])=[O:21]참가 물질
반응물 4
생성물 1
시약·촉매·용매 2
실험 절차
2,2,2-Trifluoro-1-[3-fluoro-3-(trifluoromethyl)phenyl]ethanamine (2.07 g, 8.54 mmol) was dissolved in N,N-dimethylformamide (6 ml), and 5-(methoxycarbonyl)-6-methyl-1H-pyrrolo[2,3-b]pyridine-2-carboxylic acid (1.60 g, 6.83 mmol), N-[(1H-benzotriazol-1-yloxy)(dimethylamino)methylene]-N-methylmethanaminium hexafluorophosphate (2.56 g, 6.83 mmol) and 4-methylmorpholine (2.53 ml, 20.50 mmol) were added. The reaction mixture was stirred at room temperature for 16 h and then water was added. The aqueous phase was extracted three times with ethyl acetate and the extract was dried over sodium sulphate, adsorbed on silica gel and chromatographed with ethyl acetate. This gave 1.74 g (55% of theory) of methyl 6-methyl-2-({2,2,2-trifluoro-1-[3-(trifluoromethyl)phenyl]ethyl}carbamoyl)-1H-pyrrolo[2,3-b]pyridine-5-carboxylate. HPLC-MS: log P=3.37; mass (m/z): 460.1 (M+H)+; 1H-NMR (D6-DMSO): δ 2.79 (s, 3H), 3.87 (s, 2H), 6.29-6.32 (m, 1H), 7.50 (s, 1H), 7.70-7.74 (m, 1H), 7.82-7.84 (m, 1H), 8.05 (d, 1H), 8.18 (s, 1H), 8.66 (m, 1H), 9.72-9.74 (m, 1H).
후처리
- extractionThe aqueous phase was extracted three times with ethyl acetate
- dry with materialthe extract was dried over sodium sulphate
- customchromatographed with ethyl acetate
출처 및 근거
- ORD 기록
- ord-4d0df455f9354ec1a2c7a725b3627ca4
- 출처 데이터셋
- uspto-grants-2016_05
- 특허 번호
- US09345247B2
반응 노트
불러오는 중…